Lifestyle and behavioral interventions remain the foundation for obesity management.
However, as standalone therapies, the rates of success are limited with marked heterogeneity
in response. We aimed to determine the efficacy and safety of the 32 weeks adjustable
fluid-filled intragastric balloon system (Spatz 3, Spatz FGIA, Great Neck, NY) for
weight loss.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.
